FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved a supplemental application for ziprasidone hydrochloride from BluePoint Laboratories, authorizing its generic product to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• ZIPRASIDONE HYDROCHLORIDE (Ziprasidone hydrochloride)

Snippet

SUPPL AP for ZIPRASIDONE HYDROCHLORIDE (ZIPRASIDONE HYDROCHLORIDE)